[1] THIERRY VASSELON. TLR2 recognizes a bacterial lipopeptide through direct binding.[J]. Journal of immunology, 2004, 173 12: 7401-7405. DOI:
10.4049/jimmunol.173.12.7401[2] A REITERMANN. Lipopeptide derivatives of bacterial lipoprotein constitute potent immune adjuvants combined with or covalently coupled to antigen or hapten.[J]. Biological chemistry Hoppe-Seyler, 1989, 370 4: 343-352. DOI:
10.1515/bchm3.1989.370.1.343[3] ATSUKI FUKUSHIMA. TLR2 agonist ameliorates murine experimental allergic conjunctivitis by inducing CD4 positive T-cell apoptosis rather than by affecting the Th1/Th2 balance[J]. Biochemical and biophysical research communications, 2006, 339 4: Pages 1048-1055. DOI:
10.1016/j.bbrc.2005.11.114[4] LU HUANG Susana M Meleana Hinchman. Coinjection with TLR2 agonist Pam3CSK4 reduces the pathology of leishmanization in mice.[J]. PLoS Neglected Tropical Diseases, 2015: e0003546. DOI:
10.1371/journal.pntd.0003546